Results 121 to 130 of about 2,830 (159)

The genetic architecture of Parkinson's disease in Mexico: a systematic review. [PDF]

Front Aging Neurosci
Arias-Carrión O, Romero-Gutiérrez E, Castellanos-Juárez FX, Sandoval-Carrillo AA, Salas-Pacheco JM.   +4 more
europepmc   +1 more source

Genetic Modifiers of Parkinson's Disease: A Case-Control Study. [PDF]

Ann Clin Transl Neurol
Kmiecik MJ, Holmes MV, Fontanillas P, Riboldi GM, Schneider RB, Shi J, Guan A, Tat S, Micheletti S, Stagaman K, Gottesman J, Hinds DA, Tung JY, 23andMe Research Team, Aslibekyan S, Norcliffe-Kaufmann L.   +15 more
europepmc   +1 more source

Association of Sporadic and Genetic Parkinson's Disease with Cancer: Insights from the PPMI Cohort. [PDF]

Genes (Basel)
Sfikas E, Koros C.
europepmc   +1 more source

Investigating causal relations between brain morphology and genetic risk variants in Parkinson's disease. [PDF]

Neuroimage Clin
Dagasso G, Vigneshwaran V, Winder AJ, Souza R, Ohara EY, Wilms M, Forkert ND.   +6 more
europepmc   +1 more source

Enzyme Activity-Based Genome-wide Screening for Modifiers of Lysosomal Glucocerebrosidase Uncovers Candidate Risk Factors for Parkinson's Disease. [PDF]

ACS Cent Sci
Udayar V, Gilormini PA, Bryois J, Gehrlein A, Chen X, Sonea S, Zhu S, Deen MC, Anastasi N, Murphy AE, Skene N, Tan MMX, Tunold JA, Roudnicky F, van de Berg WDJ, Pihlstrøm L, Vocadlo DJ, Jagasia R.   +17 more
europepmc   +1 more source

Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a <i>GBA1</i> Pathogenic Variant. [PDF]

Neurology
Avenali M, Artusi CA, Cilia R, Giannini G, Cuconato G, Albanese A, Golfrè Andreasi N, Antenucci P, Antonini A, Avanzino L, Baldelli L, Bentivoglio AR, Bove F, Bozzali M, Calandra-Buonaura G, Cani I, Carelli V, Cavallieri F, Cocco A, Cogiamanian F, Colucci F, Cortelli P, De Biase A, Di Biasio F, Di Fonzo A, D'Onofrio V, Eleopra R, Elia AE, Fioravanti V, Genovese D, Guerra A, Imarisio A, Ledda C, Liccari M, Longo C, Lopiano L, Malaguti MC, Malito R, Mameli F, Marino S, Minardi R, Mitrotti P, Monfrini E, Pacchetti C, Piano C, Rispoli V, Rizzone MG, Romito LM, Sambati L, Sensi M, Sorbera C, Spagnolo F, Tassorelli C, Valentino F, Valzania F, Zangaglia R, Zibetti M, Italian PARKNET Study Group, Valente EM.   +58 more
europepmc   +1 more source

Precision genomic profiling in Gaucher disease: insights from atypical presentations. [PDF]

Front Genet
Saith A, Ain NU, Ruan J, Kasaiyan M, Jain D, Israel G, Mehta S, Bamford NS, Nair S, Mistry PK.   +9 more
europepmc   +1 more source

Secondary Mitochondrial Dysfunction in Gaucher Disease Type I, II and III-Review of the Experimental and Clinical Evidence. [PDF]

Genes (Basel)
Dewsbury M, Purcell T, Hughes D, Donald A, Hargreaves IP, Stepien KM.   +5 more
europepmc   +1 more source

Lysosomal glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway contributing to Parkinson's disease. [PDF]

Proc Natl Acad Sci U S A
Nair SV, Jaimon E, Adhikari A, Nikoloff J, Pfeffer SR.   +4 more
europepmc   +1 more source

Targeting Lysosomal pH Restores Mitochondrial Quality Control in GBA1-Mutant Parkinson’s Disease

Sheshadri P, Besada MAC, Fisher A, Kiraly S, Singh K, Kourouzidou I, Blacker TS, Zeng J, Shirihai OS, Grinstaff MW, Duchen MR.   +10 more
europepmc   +1 more source